Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
RVNC | Revance Therapeutics, Inc. | Common Stock | 1.54% | $5.88M | 1.61M | Patrick Lee, MD | Sep 30, 2024 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|